-
M. Andrew Morse, MD, FSCAI,
CardiologyAortic Stenosis: Shift Toward Broader Evaluation - 14 day(s) agoDear readers, The assessment of aortic stenosis (AS) has traditionally been centered on measuring the narrowing of the aortic valve through cardiovascular imaging. However, recent…
Cardiology With M. Andrew Morse, MD, FSCAI
CardiologyDr. Morse is currently the chief of interventional cardiology and director of valvular and structural heart disease at Ascension Saint Thomas Hospital West in Nashville, Tennessee. He completed his training at Emory and Northwestern Universities, is active in medical device research, and is a member of several national trial steering committees.
-
M. Andrew Morse, MD, FSCAI,
CardiologyALIGN-AR Trial Explores Efficacy of Trilogy Heart Valve System - 2 month(s) agoDear readers, Aortic regurgitation remains a complex condition to accurately quantify with imaging and address with non-surgical treatments. Exciting developments from TCT 2023 (#TCTMD) included…
-
M. Andrew Morse, MD, FSCAI,
CardiologyAntithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation - 2 month(s) agoDear readers, Current approaches to antithrombotic therapy following left atrial appendage occlusion (LAAO) are continually evolving. In the past, patients typically received 81-325 mg of…
-
M. Andrew Morse, MD, FSCAI,
CardiologyAspiration Thrombectomy Updates - 1 year(s) agoDear Readers, Despite the controversial history of routine aspiration thrombectomy in acute myocardial infarction (MI), the technology and techniques continue to evolve. The body of…
-
M. Andrew Morse, MD, FSCAI,
CardiologyDear Readers, The presence of large thrombus burden during acute myocardial infarctions continues to present a challenging clinical scenario for interventionalists. Numerous trials have been…
-
M. Andrew Morse, MD, FSCAI,
CardiologyDay #3 of #ACC23 - Cardiac Care for Athletes - 1 year(s) agoDear readers, There was no shortage this year (#ACC23) of interesting data around athletes with inheritable heart conditions. Recent events (including Damar Hamlin) of athletes…
-
M. Andrew Morse, MD, FSCAI,
CardiologyWelcome to New Orleans - Day 2 of #ACC23 - 1 year(s) agoDear readers, As day 2 of #ACC23 kicks off the agenda is packed with interesting scientific presentations. The TRILUMINATE pivotal trial results were delivered yesterday…
-
M. Andrew Morse, MD, FSCAI,
CardiologyValvular Heart Disease Updates - #ACC2023 off to a great start! - 1 year(s) ago#ACC2023 in New Orleans has continue deliver on interesting and sometimes controversial topics in valvular heart disease. TAVR (transcatheter aortic valve replacement) programs continue to…
-
M. Andrew Morse, MD, FSCAI,
Cardiology
-
M. Andrew Morse, MD, FSCAI,
Cardiology